Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms

por Becker, Anna, Schalin-Jäntti, Camilla, Itkonen, Outi
Publicado 2021

Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report

por Ryhänen, Eeva M., Schalin-Jäntti, Camilla, Matikainen, Niina
Publicado 2021

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms

por Storvall, Sara, Ryhänen, Eeva, Karhu, Auli, Schalin-Jäntti, Camilla
Publicado 2023

A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion

por Schalin-Jäntti, Camilla, Raade, Merja, Hämäläinen, Esa, Sane, Timo
Publicado 2015

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma

por Karhapää, Hanna, Mäkelä, Siru, Laurén, Hanna, Jaakkola, Marjut, Schalin-Jäntti, Camilla, Hernberg, Micaela
Publicado 2022

Impaired breathing, sleeping, vitality, and depression, and negative impact of L-T4 treatment characterize health-related quality of life in older people with stable CVD

por Ojala, Anna K., Sintonen, Harri, Roine, Risto P., Strandberg, Timo E., Schalin-Jäntti, Camilla
Publicado 2020

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)

por Casey, Ruth T, Valk, Gerlof D, Schalin-Jäntti, Camilla, Grossman, Ashley B, Thakker, Rajesh V
Publicado 2020

Somatostatin receptor expression in parathyroid neoplasms

por Storvall, Sara, Leijon, Helena, Ryhänen, Eeva, Louhimo, Johanna, Haglund, Caj, Schalin-Jäntti, Camilla, Arola, Johanna
Publicado 2019

Mutation Analysis of Inhibitory Guanine Nucleotide Binding Protein Alpha (GNAI) Loci in Young and Familial Pituitary Adenomas

por Demir, Hande, Donner, Iikki, Kivipelto, Leena, Kuismin, Outi, Schalin-Jäntti, Camilla, De Menis, Ernesto, Karhu, Auli
Publicado 2014

Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument

por Ryhänen, Eeva M, Heiskanen, Ilkka, Sintonen, Harri, Välimäki, Matti J, Roine, Risto P, Schalin-Jäntti, Camilla
Publicado 2015

Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients

por Iivonen, Anna-Pauliina, Känsäkoski, Johanna, Karppinen, Atte, Kivipelto, Leena, Schalin-Jäntti, Camilla, Karhu, Auli, Raivio, Taneli
Publicado 2018

An overview of the outreach of the 2019–2021 Endo-ERN knowledge generation webinars

por Iotova, Violeta, Schalin-Jäntti, Camilla, Van Beuzekom, Charlotte, Bruegmann, Petra, Broesamle, Manuela, Hiort, Olaf, Pereira, Alberto M
Publicado 2023

Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss‐of‐Function Gα(11) Mutation

por Gorvin, Caroline M, Hannan, Fadil M, Cranston, Treena, Valta, Helena, Makitie, Outi, Schalin‐Jantti, Camilla, Thakker, Rajesh V
Publicado 2017

Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide

por Storvall, Sara, Ryhänen, Eeva, Bensch, Frank V, Heiskanen, Ilkka, Kytölä, Soili, Ebeling, Tapani, Mäkelä, Siru, Schalin‐Jäntti, Camilla
Publicado 2018

Educational and knowledge gaps within the European reference network on rare endocrine conditions

por Iotova, Violeta, Schalin-Jäntti, Camilla, Bruegmann, Petra, Broesamle, Manuela, Bratina, Natasa, Tillmann, Vallo, Hiort, Olaf, Pereira, Alberto M
Publicado 2020

CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma

por Korpi-Hyövälti, Eeva, Cranston, Treena, Ryhänen, Eeva, Arola, Johanna, Aittomäki, Kristiina, Sane, Timo, Thakker, Rajesh V., Schalin-Jäntti, Camilla
Publicado 2014

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism

por Ryhänen, Eeva M., Schildt, Jukka, Heiskanen, Ilkka, Väisänen, Mika, Ahonen, Aapo, Löyttyniemi, Eliisa, Schalin-Jäntti, Camilla, Välimäki, Matti J.
Publicado 2015

Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)

por Bollerslev, Jens, Schalin-Jäntti, Camilla, Rejnmark, Lars, Siggelkow, Heide, Morreau, Hans, Thakker, Rajesh, Sitges-Serra, Antonio, Cetani, Filomena, Marcocci, Claudio
Publicado 2019

Access to patient oriented information—a baseline Endo-ERN survey among patients with rare endocrine disorders

por Iotova, Violeta, Schalin-Jäntti, Camilla, Bruegmann, Petra, Broesamle, Manuela, De Graaf, Johan, Bratina, Natasa, Tillmann, Vallo, Pereira, Alberto M., Hiort, Olaf
Publicado 2021

MGMT Promoter Methylation and Parathyroid Carcinoma

por Storvall, Sara, Ryhänen, Eeva, Heiskanen, Ilkka, Vesterinen, Tiina, Bensch, Frank V, Schildt, Jukka, Kytölä, Soili, Karhu, Auli, Arola, Johanna, Schalin-Jäntti, Camilla
Publicado 2019